Medicine and Health Sciences Commons^™

Treatment Effects Of The Edgewise Bioprogressive Herbst Appliance, Bernard C. Chang

Loma Linda University Electronic Theses, Dissertations & Projects

The effect of the Edgewise Bioprogressive Herbst appliance, as described by Dr. Terry Dischinger, was investigated on 24 Class II, Division 1 malocclusions. Mean pretreatment age of this sample was 11.2 months. All patients were treated by Dischinger with a Bioprogressive Herbst appliance. Lateral cephalographs taken before, after Herbst appliance therapy, and after edgewise treatment were traced, then digitized into Quick Ceph™. Measurements were computed by the computer software. The following results were found: 1) Average treatment time was 9 months. 2) An overcorrected Class I relationship was achieved. 3) Class II malocclusion was corrected by 4.5 mm skeletal alteration …

Mutagenecity Of Formocresol, Glutaraldehyde, Ferric Sulfate And Aluminum Chloride : Materials Used In Therapeutic Pulpotomies, Adolfo Barrera

Loma Linda University Electronic Theses, Dissertations & Projects

Ferric sulfate (Astringedent) and aluminum chloride (Hemodent) have been proposed as possible medicaments for use in primary teeth for therapeutic pulpotomies.

There is little information in the literature about the biologic properties of these medicaments.

The purpose of this study was to evaluate the mutagenic response of the ferric sulfate and aluminum chloride and compare them with glutaraldehyde (1.5%, 1% and 0.5% concentration) and formocresol (2%, 0.75%, 0.01% and 0.005% concentration). TA98 and TA1535 strain were used in the Ames test to assess mutagenecity. Neither ferric sulfate nor aluminum chloride exhibited mutagenic potential, in comparison with glutaraldehyde and formocresol, which …